Annual Operating Profit
-$6.92 M
-$2.47 M-55.56%
30 April 2024
Summary:
Champions Oncology annual operaing income is currently -$6.92 million, with the most recent change of -$2.47 million (-55.56%) on 30 April 2024. During the last 3 years, it has fallen by -$7.29 million (-1990.98%). CSBR annual operating profit is now -1240.20% below its all-time high of $607.00 thousand, reached on 30 April 2022.CSBR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$1.33 M
+$1.17 M+710.37%
31 July 2024
Summary:
Champions Oncology quarterly operating income is currently $1.33 million, with the most recent change of +$1.17 million (+710.37%) on 31 July 2024. Over the past year, it has increased by +$3.28 million (+167.98%). CSBR quarterly operating profit is now at all-time high.CSBR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$3.04 M
+$3.88 M+56.08%
31 July 2024
Summary:
Champions Oncology TTM operating income is currently -$3.04 million, with the most recent change of +$3.88 million (+56.08%) on 31 July 2024. Over the past year, it has increased by +$5.64 million (+64.98%). CSBR TTM operating profit is now -600.66% below its all-time high of $607.00 thousand, reached on 30 April 2022.CSBR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.6% | +168.0% | +65.0% |
| 3 y3 years | -1991.0% | +405.3% | -820.1% |
| 5 y5 years | -2663.3% | +356.7% | -275.6% |
CSBR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1240.2% | at low | at high | +151.6% | -600.7% | +65.5% |
| 5 y | 5 years | -1240.2% | at low | at high | +151.6% | -600.7% | +65.5% |
| alltime | all time | -1240.2% | +47.7% | at high | +135.6% | -600.7% | +77.0% |
Champions Oncology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $1.33 M(+710.4%) | -$3.04 M(-56.1%) |
| Apr 2024 | -$6.92 M(+55.6%) | $164.00 K(-106.4%) | -$6.92 M(-21.3%) |
| Jan 2024 | - | -$2.58 M(+31.8%) | -$8.80 M(+1.4%) |
| Oct 2023 | - | -$1.96 M(-23.4%) | -$8.68 M(+29.2%) |
| July 2023 | - | -$2.55 M(+48.9%) | -$6.72 M(+51.0%) |
| Apr 2023 | -$4.45 M(-832.9%) | -$1.71 M(-30.3%) | -$4.45 M(+46.1%) |
| Jan 2023 | - | -$2.46 M(<-9900.0%) | -$3.05 M(-1358.7%) |
| Oct 2022 | - | $7000.00(-102.5%) | $242.00 K(-51.4%) |
| July 2022 | - | -$284.00 K(-8.7%) | $498.00 K(-18.0%) |
| Apr 2022 | $607.00 K(+65.8%) | -$311.00 K(-137.5%) | $607.00 K(+124.8%) |
| Jan 2022 | - | $830.00 K(+215.6%) | $270.00 K(-36.0%) |
| Oct 2021 | - | $263.00 K(-250.3%) | $422.00 K(+154.2%) |
| July 2021 | - | -$175.00 K(-73.0%) | $166.00 K(-54.4%) |
| Apr 2021 | $366.00 K(-123.1%) | -$648.00 K(-166.0%) | $364.00 K(-153.3%) |
| Jan 2021 | - | $982.00 K(>+9900.0%) | -$683.00 K(-44.6%) |
| Oct 2020 | - | $7000.00(-69.6%) | -$1.23 M(+30.0%) |
| July 2020 | - | $23.00 K(-101.4%) | -$948.00 K(-40.2%) |
| Apr 2020 | -$1.59 M(-687.4%) | -$1.70 M(-491.5%) | -$1.58 M(>+9900.0%) |
| Jan 2020 | - | $433.00 K(+48.8%) | -$6000.00(-99.3%) |
| Oct 2019 | - | $291.00 K(-147.4%) | -$809.00 K(-1.9%) |
| July 2019 | - | -$614.00 K(+429.3%) | -$825.00 K(-405.6%) |
| Apr 2019 | $270.00 K(-119.9%) | -$116.00 K(-68.6%) | $270.00 K(-226.8%) |
| Jan 2019 | - | -$370.00 K(-234.5%) | -$213.00 K(-336.7%) |
| Oct 2018 | - | $275.00 K(-42.8%) | $90.00 K(-135.3%) |
| July 2018 | - | $481.00 K(-180.3%) | -$255.00 K(-81.2%) |
| Apr 2018 | -$1.35 M(-80.1%) | -$599.00 K(+794.0%) | -$1.35 M(-56.9%) |
| Jan 2018 | - | -$67.00 K(-4.3%) | -$3.15 M(-29.8%) |
| Oct 2017 | - | -$70.00 K(-88.7%) | -$4.48 M(-8.6%) |
| July 2017 | - | -$619.00 K(-74.1%) | -$4.90 M(-28.0%) |
| Apr 2017 | -$6.81 M(-34.0%) | -$2.39 M(+70.5%) | -$6.81 M(-2.3%) |
| Jan 2017 | - | -$1.40 M(+184.2%) | -$6.97 M(-12.2%) |
| Oct 2016 | - | -$493.00 K(-80.5%) | -$7.94 M(-20.1%) |
| July 2016 | - | -$2.52 M(-1.0%) | -$9.94 M(-3.6%) |
| Apr 2016 | -$10.32 M(-22.1%) | -$2.55 M(+7.4%) | -$10.31 M(+1.4%) |
| Jan 2016 | - | -$2.37 M(-4.8%) | -$10.17 M(-9.3%) |
| Oct 2015 | - | -$2.49 M(-13.9%) | -$11.21 M(-9.5%) |
| July 2015 | - | -$2.90 M(+20.5%) | -$12.39 M(-6.3%) |
| Apr 2015 | -$13.24 M(+111.5%) | -$2.40 M(-29.7%) | -$13.22 M(+0.2%) |
| Jan 2015 | - | -$3.42 M(-6.7%) | -$13.19 M(+18.0%) |
| Oct 2014 | - | -$3.67 M(-1.7%) | -$11.18 M(+21.3%) |
| July 2014 | - | -$3.73 M(+56.8%) | -$9.22 M(+47.4%) |
| Apr 2014 | -$6.26 M(+0.6%) | -$2.38 M(+68.9%) | -$6.25 M(+6.7%) |
| Jan 2014 | - | -$1.41 M(-17.2%) | -$5.86 M(+13.3%) |
| Oct 2013 | - | -$1.70 M(+122.1%) | -$5.17 M(-4.0%) |
| July 2013 | - | -$766.00 K(-61.4%) | -$5.39 M(-13.4%) |
| Apr 2013 | -$6.22 M(-31.4%) | -$1.99 M(+175.8%) | -$6.22 M(-9.0%) |
| Jan 2013 | - | -$720.00 K(-62.4%) | -$6.84 M(-13.3%) |
| Oct 2012 | - | -$1.92 M(+19.8%) | -$7.89 M(-6.5%) |
| July 2012 | - | -$1.60 M(-38.5%) | -$8.44 M(-6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | -$9.06 M(+73.2%) | -$2.60 M(+46.8%) | -$9.06 M(-2.5%) |
| Jan 2012 | - | -$1.77 M(-28.2%) | -$9.29 M(+11.9%) |
| Oct 2011 | - | -$2.47 M(+11.5%) | -$8.31 M(+21.2%) |
| July 2011 | - | -$2.21 M(-22.0%) | -$6.85 M(+30.7%) |
| Apr 2011 | -$5.24 M(+78.8%) | -$2.84 M(+261.2%) | -$5.24 M(+77.4%) |
| Jan 2011 | - | -$786.00 K(-22.6%) | -$2.96 M(+0.1%) |
| Oct 2010 | - | -$1.01 M(+68.3%) | -$2.95 M(+17.1%) |
| July 2010 | - | -$603.00 K(+9.2%) | -$2.52 M(-13.8%) |
| Apr 2010 | -$2.93 M(+43.1%) | -$552.00 K(-29.6%) | -$2.93 M(-16.3%) |
| Jan 2010 | - | -$784.00 K(+34.2%) | -$3.50 M(+6.1%) |
| Oct 2009 | - | -$584.00 K(-42.1%) | -$3.30 M(+11.0%) |
| July 2009 | - | -$1.01 M(-10.3%) | -$2.97 M(+40.4%) |
| Apr 2009 | -$2.05 M(+365.0%) | -$1.12 M(+92.5%) | -$2.12 M(+12.0%) |
| Jan 2009 | - | -$584.00 K(+127.5%) | -$1.89 M(+169.4%) |
| Oct 2008 | - | -$256.70 K(+68.9%) | -$701.80 K(+17.9%) |
| July 2008 | - | -$152.00 K(-83.1%) | -$595.30 K(+35.3%) |
| Apr 2008 | -$440.00 K(+158.7%) | -$898.00 K(-248.5%) | -$440.10 K(-221.6%) |
| Jan 2008 | - | $604.90 K(-502.7%) | $361.90 K(-229.2%) |
| Oct 2007 | - | -$150.20 K(-4793.8%) | -$280.20 K(+87.3%) |
| July 2007 | - | $3200.00(-103.3%) | -$149.60 K(-12.1%) |
| Apr 2007 | -$170.10 K(+18.0%) | -$96.00 K(+158.1%) | -$170.10 K(+138.2%) |
| Jan 2007 | - | -$37.20 K(+89.8%) | -$71.40 K(-361.5%) |
| Oct 2006 | - | -$19.60 K(+13.3%) | $27.30 K(+780.6%) |
| July 2006 | - | -$17.30 K(-740.7%) | $3100.00(-106.3%) |
| Apr 2006 | -$144.10 K(+36.6%) | $2700.00(-95.6%) | -$49.60 K(-229.8%) |
| Jan 2006 | - | $61.50 K(-240.4%) | $38.20 K(0.0%) |
| Oct 2005 | - | -$43.80 K(-37.4%) | $38.20 K(+496.9%) |
| July 2005 | - | -$70.00 K(-177.3%) | $6400.00(-63.6%) |
| Apr 2005 | -$105.50 K(-2.0%) | $90.50 K(+47.2%) | $17.60 K(+576.9%) |
| Jan 2005 | - | $61.50 K(-181.3%) | $2600.00(-102.3%) |
| Oct 2004 | - | -$75.60 K(+28.6%) | -$112.90 K(+61.5%) |
| July 2004 | - | -$58.80 K(-177.9%) | -$69.90 K(+19.7%) |
| Apr 2004 | -$107.70 K(-26.2%) | $75.50 K(-239.8%) | -$58.40 K(-70.5%) |
| Jan 2004 | - | -$54.00 K(+65.6%) | -$198.20 K(+5.8%) |
| Oct 2003 | - | -$32.60 K(-31.1%) | -$187.30 K(+59.0%) |
| July 2003 | - | -$47.30 K(-26.4%) | -$117.80 K(-19.3%) |
| Apr 2003 | -$146.00 K(-0.9%) | -$64.30 K(+49.2%) | -$146.00 K(-9.3%) |
| Jan 2003 | - | -$43.10 K(-216.8%) | -$161.00 K(+3.9%) |
| Oct 2002 | - | $36.90 K(-148.9%) | -$155.00 K(-17.9%) |
| July 2002 | - | -$75.50 K(-4.8%) | -$188.90 K(+28.2%) |
| Apr 2002 | -$147.30 K(-68.6%) | -$79.30 K(+113.7%) | -$147.30 K(+4.6%) |
| Jan 2002 | - | -$37.10 K(-1336.7%) | -$140.80 K(-63.1%) |
| Oct 2001 | - | $3000.00(-108.8%) | -$381.30 K(-29.9%) |
| July 2001 | - | -$33.90 K(-53.4%) | -$544.00 K(+16.0%) |
| Apr 2001 | -$468.90 K(-3226.0%) | -$72.80 K(-73.8%) | -$468.90 K(-2.5%) |
| Jan 2001 | - | -$277.60 K(+73.8%) | -$481.10 K(+136.4%) |
| Oct 2000 | - | -$159.70 K(-487.6%) | -$203.50 K(+364.6%) |
| July 2000 | - | $41.20 K(-148.5%) | -$43.80 K(-48.5%) |
| Apr 2000 | $15.00 K | -$85.00 K(<-9900.0%) | -$85.00 K(<-9900.0%) |
| Jan 2000 | - | $0.00 | $0.00 |
FAQ
- What is Champions Oncology annual operaing income?
- What is the all time high annual operating profit for Champions Oncology?
- What is Champions Oncology annual operating profit year-on-year change?
- What is Champions Oncology quarterly operating income?
- What is the all time high quarterly operating profit for Champions Oncology?
- What is Champions Oncology quarterly operating profit year-on-year change?
- What is Champions Oncology TTM operating income?
- What is the all time high TTM operating profit for Champions Oncology?
- What is Champions Oncology TTM operating profit year-on-year change?
What is Champions Oncology annual operaing income?
The current annual operating profit of CSBR is -$6.92 M
What is the all time high annual operating profit for Champions Oncology?
Champions Oncology all-time high annual operaing income is $607.00 K
What is Champions Oncology annual operating profit year-on-year change?
Over the past year, CSBR annual operaing income has changed by -$2.47 M (-55.56%)
What is Champions Oncology quarterly operating income?
The current quarterly operating profit of CSBR is $1.33 M
What is the all time high quarterly operating profit for Champions Oncology?
Champions Oncology all-time high quarterly operating income is $1.33 M
What is Champions Oncology quarterly operating profit year-on-year change?
Over the past year, CSBR quarterly operating income has changed by +$3.28 M (+167.98%)
What is Champions Oncology TTM operating income?
The current TTM operating profit of CSBR is -$3.04 M
What is the all time high TTM operating profit for Champions Oncology?
Champions Oncology all-time high TTM operating income is $607.00 K
What is Champions Oncology TTM operating profit year-on-year change?
Over the past year, CSBR TTM operating income has changed by +$5.64 M (+64.98%)